Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Riendeau

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Biochemistry|September 21, 1993
Characterization of the non-heme iron center of human 5-lipoxygenase by electron paramagnetic resonance, fluorescence, and ultraviolet-visible spectroscopy: redox cycling between ferrous and ferric statesN D Chasteen, J K Grady, K I Skorey, et al.
Journal of Medicinal Chemistry|September 17, 1993
Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816J H Hutchinson, D Riendeau, C Brideau, et al.
American Journal of Physiology. Renal Physiology|November 13, 2001
Urogenital distribution of a mouse membrane-associated prostaglandin E(2) synthaseY Guan, Y Zhang, A Schneider, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 1999
2-heterosubstituted-3-(4-methylsulfonyl)phenyl-5-trifluoromethyl pyridines as selective and orally active cyclooxygenase-2 inhibitorsD Dubé, C Brideau, D Deschênes, et al.
The Journal of Biological Chemistry|June 3, 1994
Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged plateletsD Riendeau, J Guay, P K Weech, et al.
Journal of Medicinal Chemistry|April 15, 1994
Thiopyrano[2,3,4-cd]indoles as 5-lipoxygenase inhibitors: synthesis, biological profile, and resolution of 2-[2-[1-(4-chlorobenzyl)-4-methyl-6-[(5-phenylpyridin-2-yl)methoxy]-4,5 -dihydro-1H-thiopyrano[2,3,4-cd]indol-2-yl]ethoxy]butanoic acidJ H Hutchinson, D Riendeau, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2001
In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663)N Chauret, J A Yergey, C Brideau, et al.
Journal of Medicinal Chemistry|April 3, 1992
Development of 2,3-dihydro-6-(3-phenoxypropyl)-2-(2-phenylethyl)-5-benzofuranol (L-670,630) as a potent and orally active inhibitor of 5-lipoxygenaseC K Lau, P C Bélanger, C Dufresne, et al.
Journal of Medicinal Chemistry|January 5, 2001
Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and LJ P Falgueyret, R M Oballa, O Okamoto, et al.
Journal of Medicinal Chemistry|February 18, 1994
Naphthalenic lignan lactones as selective, nonredox 5-lipoxygenase inhibitors. Synthesis and biological activity of (methoxyalkyl)thiazole and methoxytetrahydropyran hybridsY Ducharme, C Brideau, D Dubé, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Biochemistry|September 21, 1993
Characterization of the non-heme iron center of human 5-lipoxygenase by electron paramagnetic resonance, fluorescence, and ultraviolet-visible spectroscopy: redox cycling between ferrous and ferric statesN D Chasteen, J K Grady, K I Skorey, et al.
Journal of Medicinal Chemistry|September 17, 1993
Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816J H Hutchinson, D Riendeau, C Brideau, et al.
American Journal of Physiology. Renal Physiology|November 13, 2001
Urogenital distribution of a mouse membrane-associated prostaglandin E(2) synthaseY Guan, Y Zhang, A Schneider, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 1999
2-heterosubstituted-3-(4-methylsulfonyl)phenyl-5-trifluoromethyl pyridines as selective and orally active cyclooxygenase-2 inhibitorsD Dubé, C Brideau, D Deschênes, et al.
The Journal of Biological Chemistry|June 3, 1994
Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged plateletsD Riendeau, J Guay, P K Weech, et al.
Journal of Medicinal Chemistry|April 15, 1994
Thiopyrano[2,3,4-cd]indoles as 5-lipoxygenase inhibitors: synthesis, biological profile, and resolution of 2-[2-[1-(4-chlorobenzyl)-4-methyl-6-[(5-phenylpyridin-2-yl)methoxy]-4,5 -dihydro-1H-thiopyrano[2,3,4-cd]indol-2-yl]ethoxy]butanoic acidJ H Hutchinson, D Riendeau, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2001
In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663)N Chauret, J A Yergey, C Brideau, et al.
Journal of Medicinal Chemistry|April 3, 1992
Development of 2,3-dihydro-6-(3-phenoxypropyl)-2-(2-phenylethyl)-5-benzofuranol (L-670,630) as a potent and orally active inhibitor of 5-lipoxygenaseC K Lau, P C Bélanger, C Dufresne, et al.
Journal of Medicinal Chemistry|January 5, 2001
Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and LJ P Falgueyret, R M Oballa, O Okamoto, et al.
Journal of Medicinal Chemistry|February 18, 1994
Naphthalenic lignan lactones as selective, nonredox 5-lipoxygenase inhibitors. Synthesis and biological activity of (methoxyalkyl)thiazole and methoxytetrahydropyran hybridsY Ducharme, C Brideau, D Dubé, et al.
Pageof 8